Literature DB >> 8449682

Platelet-derived growth factor: receptor expression in corneas and effects on corneal cells.

V P Hoppenreijs1, E Pels, G F Vrensen, P C Felten, W F Treffers.   

Abstract

PURPOSE: Platelet-derived growth factor (PDGF), a major mitogen and chemoattractant, is a dimeric molecule of disulfide-bonded A and/or B polypeptide chains (PDGF-AA/AB/BB). Two PDGF receptors (PDGFR) exist, alpha and beta, which dimerize after ligand exposure. The alpha-receptor binds both A- and B-chains, whereas the beta-receptor preferentially binds the B-chain. Whether PDGFR are present on, and whether PDGF is mitogenic for, corneal cells was investigated.
METHODS: For receptor determination, a two-step immunoperoxidase technique with monoclonal antibodies against both alpha- and beta-receptors was applied on frozen sections of human and bovine corneas. To test the mitogenic activity of PDGF-BB, two proliferation assays, the DNA synthesis assay (3H-thymidine incorporation) and the colorimetric MTT assay, were used for cultured bovine corneal endothelial cells (BCEC) and human corneal fibroblast (HCF).
RESULTS: Both receptors were present on epithelial cells, stromal fibroblasts, and endothelial cells, the beta-receptor being most abundant. In BCEC, minimal and maximal effects on DNA synthesis occurred at 10 ng/ml and 50-100 ng/ml PDGF, respectively. For HCF, the minimal and maximal effective doses were 1 ng/ml and 25-100 ng/ml of PDGF, respectively. The MTT assay, carried out in BCEC only, showed a minimal and maximal cell activity at 1 ng/ml and 10-100 ng/ml of PDGF, respectively.
CONCLUSIONS: The presence of PDGFR in human corneal epithelium, fibroblasts, and endothelium and the mitogenic effects of PDGF on corneal cells indicate that PDGF may play a role in corneal wound healing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449682

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  NK cells modulate the inflammatory response to corneal epithelial abrasion and thereby support wound healing.

Authors:  Qiong Liu; C Wayne Smith; Wanyu Zhang; Alan R Burns; Zhijie Li
Journal:  Am J Pathol       Date:  2012-06-22       Impact factor: 4.307

2.  Proliferative response of cultured human tenon's capsule fibroblasts to platelet-derived growth factor isoforms.

Authors:  M Knorr; M Völker; P O Denk; K Wunderlich; H J Thiel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

3.  Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization.

Authors:  Zhang Chaoran; Lin Zhirong; Xu Gezhi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-15       Impact factor: 3.117

4.  The study of human PDGF-B gene transferred to cat corneal endothelial cells.

Authors:  Wen-Juan Luo; Xiao-Ji Wang; Xiao-Ming Xing; Chuan-Fu Wang
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

Review 5.  Proliferative capacity of corneal endothelial cells.

Authors:  Nancy C Joyce
Journal:  Exp Eye Res       Date:  2011-08-30       Impact factor: 3.467

6.  The in vitro effect of platelet-derived growth factor isoforms on the proliferation of bovine corneal stromal fibroblasts depends on cell density.

Authors:  P O Denk; M Knorr
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

Review 7.  Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).

Authors:  William Stevenson; Sheng-Fu Cheng; Mohammad H Dastjerdi; Giulio Ferrari; Reza Dana
Journal:  Ocul Surf       Date:  2012-01-25       Impact factor: 5.033

8.  Gene Expression Profile of Vascular Endothelial Growth Factors (VEGFs) and Platelet-derived Growth Factors (PDGFs) in the Normal Cornea.

Authors:  Andrei Radu Dan Cosnita; Marius Raica; Mihai Poenaru Sava; Anca Maria Cimpean
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  Lymphocyte function-associated antigen-1-dependent inhibition of corneal wound healing.

Authors:  Zhijie Li; Alan R Burns; C Wayne Smith
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 10.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.